サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1429613

放射性医薬品の世界市場レポート 2024年

Radiopharmaceuticals Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 250 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
放射性医薬品の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 250 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

放射性医薬品の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には11.8%の年間複合成長率（CAGR）で105億9,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、高齢者人口の増加、がんや心血管疾患の有病率の上昇、多額の設備投資、新製品のイントロダクションなどの要因によるものと考えられます。この時期の注目すべき動向としては、収益と製品品質を向上させるための他社との共同努力、需要の増大に対応するための工場生産能力の拡大への投資、新たな要件に対応するための新技術の採用、コスト削減のための製造への3Dプリンティング技術の導入、次のようなイノベーションへの投資などが挙げられます。治療学としての分野でのリーダーシップの追求、より合理的で科学的なアプローチのためのインシリコモデリングの模索、AIを活用して研究開発コストを削減し医薬品開発を促進すること、そして収益を増やすために心臓病に焦点を当てた技術に投資することです。さらに、がんを正確かつタイムリーに診断するために疾患に特化したアプローチを採用することは、注目すべき傾向です。

がんや心血管疾患の罹患率の増加は、放射性医薬品市場の原動力となると予想されます。 放射性医薬品は、従来の薬に代わる安全で効果的な治療法としてますます認識されています。これらは、主に標的療法の利点により、がんや心血管疾患の治療において放射線科医に明確な利点をもたらします。がんは死因の第2位にランクされており、世界の死亡者の約6人に1人ががんによるものとされています。国際がん研究機関（IARC）によると、人口増加と高齢化により、世界の負担は2040年までに現在進行中のがん発生件数は2,750万件、がんによる死亡者数は1,630万人に達すると予測されています。注目すべきことに、がんによる死亡の約70%は低所得国と中所得国で発生しています。その結果、がんや心血管疾患の有病率の増加により、これらの症状の治療における放射性医薬品の需要が高まることが予想されます。

放射性医薬品市場は、個別化医療に対する需要の高まりにより、大幅な成長が見込まれています。精密医療としても知られる個別化医療は、各患者の固有の特性に合わせて医療上の決定、治療、介入、薬物療法を調整する医療への革新的なアプローチです。個別化医療を放射性医薬品に統合することで、画像処理と治療の正確性が向上し、医療提供者はより的を絞った効果的なケアを提供できるようになります。たとえば、2022年に食品医薬品局の医薬品評価研究センター（CDER）は37の新しい分子実体（NME）を承認し、そのうちの約34%または12が個別化医療連合（PMC）によって個別化医療として分類されました。したがって、個別化医療に対する需要の高まりは、放射性医薬品市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の放射性医薬品市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の放射性医薬品市場規模実績と成長率、2018～2023年
  • 世界の放射性医薬品市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の放射性医薬品市場、タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 診断
  • 治療
  • その他
  • 世界の放射性医薬品市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 腫瘍学
  • 心臓病学
  • 消化器科
  • 神経内分泌学
  • 神経内科
  • 腎臓学
  • その他
  • 世界の放射性医薬品市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 病院
  • 外来手術センター
  • 診断センター
  • がん研究
  • その他

第7章 地域と国の分析

  • 世界の放射性医薬品市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界の放射性医薬品市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 放射性医薬品市場の競合情勢
  • 放射性医薬品市場の企業プロファイル
    • Cardinal Health
    • Curium Pharma
    • Siemens Healthineers AG
    • Novartis AG
    • General Electric Company（GE）

第31章 その他の大手と革新的な企業

  • IBA Group
  • Bayer AG
  • Lantheus Medical Imaging Inc.
  • Bracco Imaging SpA
  • Eckert &Ziegler
  • Nihon Medi-Physics Co. Ltd.
  • Fujifilm Corporation
  • ANSTO
  • Yantai Dongcheng Pharmaceutical Group Co. Ltd.
  • Bracco Imaging SpA.
  • Canon Inc.
  • China Isotope &Radiation Corporation（CIRC）
  • Alliance Medical
  • Advanced Accelerator Applications
  • JSC Isotope

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r14584

Radiopharmaceuticals, also known as radioactive medications, are substances used for the diagnosis or treatment of diseases, including cancer, and contain a radioactive material. These medications are employed in various medical procedures to identify specific illnesses or detect medical issues. Patients may receive radiopharmaceuticals through different administration methods, such as injection, oral ingestion, or application into the eye or bladder.

Radiopharmaceuticals can be broadly categorized into diagnostic, therapeutic, and other types. The process of delivering radioactive atoms to targets associated with tumors is known as radiopharmaceutical therapy. These medications find applications in fields such as oncology, cardiology, gastroenterology, neuroendocrinology, neurology, nephrology, and others. Hospitals, ambulatory surgical centers, diagnostic centers, cancer research institutes, and similar healthcare facilities commonly utilize radiopharmaceuticals for various medical purposes.

The radiopharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides radiopharmaceuticals market statistics, including radiopharmaceuticals industry global market size, regional shares, competitors with a radiopharmaceuticals market share, detailed radiopharmaceuticals market segments, market trends and opportunities, and any further data you may need to thrive in the radiopharmaceuticals industry. This radiopharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The radiopharmaceuticals market size has grown steadily in recent years. It will grow from $6.46 billion in 2023 to $6.77 billion in 2024 at a compound annual growth rate (CAGR) of 4.7%. The expansion observed in the historical period can be linked to an increase in healthcare spending, government initiatives, the convenience of treatment, and shifts in lifestyle.

The radiopharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $10.59 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. Anticipated growth in the forecast period is attributed to factors such as the increasing geriatric population, a rise in the prevalence of cancer and cardiovascular diseases, substantial capital investments, and the introduction of new products. Notable trends in this period include collaborative efforts with other companies to enhance revenues and product quality, investments in expanding plant capacity to meet growing demand, embracing new technologies to address emerging requirements, incorporating 3D printing technology in manufacturing for cost savings, investment in innovations such as theranostics, striving for category leadership, exploring in silico modeling for a more rational and scientific approach, leveraging AI to reduce research and development costs and expedite drug development, and investing in technologies focused on cardiology to boost revenues. Additionally, adopting disease-specific approaches for accurate and timely diagnosis of cancer is a noteworthy trend.

The escalating prevalence of cancer and cardiovascular diseases is expected to be a driving force for the radiopharmaceuticals market. Radiopharmaceuticals are increasingly recognized as a safe and effective therapeutic alternative to conventional medicines. They offer radiologists a distinct advantage in treating cancer and cardiovascular diseases, primarily due to their targeted therapy benefits. Cancer ranks as the second leading cause of death, with approximately 1 in 6 global deaths attributed to cancer. According to the International Agency for Research on Cancer (IARC), by 2040, the global burden is projected to reach 27.5 million active cancer incidents and 16.3 million cancer deaths, driven by population growth and aging. Notably, around 70% of cancer deaths occur in low- and middle-income countries. As a result, the increasing prevalence of cancer and cardiovascular diseases is expected to fuel the demand for radiopharmaceuticals in treating these conditions.

The radiopharmaceuticals market is anticipated to experience significant growth, driven by the increasing demand for personalized medicine. Personalized medicine, also known as precision medicine, is an innovative approach to medical care that tailors medical decisions, treatments, interventions, and drug therapies to the unique characteristics of each patient. Integrating personalized medicine into radiopharmaceuticals enhances the precision and accuracy of imaging and therapy, enabling healthcare providers to deliver more targeted and effective care. For example, in 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34%, or 12 of them, classified as personalized medicines by the Personalized Medicine Coalition (PMC). The increasing demand for personalized medicine is thus a driving force behind the growth of the radiopharmaceuticals market.

Several companies in the radiopharmaceuticals market are adopting strategic initiatives such as opening new manufacturing facilities and expanding plant capacity, gaining significant popularity. ITM Isotopen Technologien Munchen AG (ITM), for instance, launched a new manufacturing facility in the Munich area to increase the production capacity of high-purity (n.c.a.) Lutetium-177 and no-carrier-added (n.c.a.) Lutetium-177-containing radiopharmaceuticals. This move aims to meet the high demand for quality medical isotopes for precision oncology worldwide.

Major players in the radiopharmaceuticals market are forming partnerships to enhance their market profitability. In June 2023, the University of Pittsburgh Medical Center partnered with PharmaLogic Holdings Corporation to produce new radiopharmaceuticals at a Pittsburgh facility. This collaboration enables patients and professionals in the UPMC vicinity to access innovative diagnostic and therapeutic drugs that are not currently available. The non-exclusive agreement outlines the conversion of experimental radiopharmaceuticals into therapeutically useful medications.

In June 2021, Curium, a France-based nuclear medicine solutions provider, acquired IASON for an undisclosed amount. This acquisition is expected to bolster Curium's presence in Europe for its extensive range of life-saving diagnostic techniques. By expanding its geographic reach, Curium aims to serve clients and patients throughout Austria and Central Europe with its diverse range of medications and future pipeline of novel agents. IASON, based in Austria, specializes in radiopharmaceutical development, manufacturing, and distribution for use in positron-emission tomography (PET).

Major companies operating in the radiopharmaceuticals market report are Cardinal Health, Curium Pharma, Siemens Healthineers AG, Novartis AG, General Electric Company (GE), IBA Group, Bayer AG, Lantheus Medical Imaging Inc., Bracco Imaging S.p.A., Eckert & Ziegler, Nihon Medi-Physics Co. Ltd., Fujifilm Corporation, ANSTO, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Bracco Imaging SpA., Canon Inc., China Isotope & Radiation Corporation (CIRC), Alliance Medical, Advanced Accelerator Applications, JSC Isotope, Pharm-Sintez, Synektik SA, Polatom, RadioMedic sro, UJV Rez, Actinium Pharmaceuticals Inc., Alseres Pharmaceuticals Inc., Avid Radiopharmaceuticals, Fusion Pharmaceuticals, Peregrine Pharmaceuticals Inc., PETNET Solutions Inc., Positron Corporation, Triad Isotopes Inc., Telix Pharmaceuticals, Rosatom, Alliance Medical Group, Hologic Inc., Segami Corporation, Eczacybaþy-Monrol Nuclear Products, NTP Radioisotopes.

North America was the largest region in the global radiopharmaceuticals market in 2023. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the radiopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the radiopharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The radiopharmaceuticals market consists of sales of technetium disofenin, technetium lidofenin, and technetium mebrofenin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiopharmaceuticals Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiopharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiopharmaceuticals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The radiopharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Diagnostic; Therapeutic
  • 2) By Application: Oncology; Cardiology; Gastroenterology; Neuroendocrinology; Musculoskeletal; Respiratory; Nephrology; Other Applications
  • 3) By End User: Hospitals And Ambulatory Surgical Centers; Diagnostic Centers; Cancer Research Institutes
  • Companies Mentioned: Cardinal Health; Curium Pharma; Siemens Healthineers AG; Novartis AG; General Electric Company (GE)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Radiopharmaceuticals Market Characteristics

3. Radiopharmaceuticals Market Trends And Strategies

4. Radiopharmaceuticals Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Radiopharmaceuticals Market Size and Growth

  • 5.1. Global Radiopharmaceuticals Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Radiopharmaceuticals Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Radiopharmaceuticals Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Radiopharmaceuticals Market Segmentation

  • 6.1. Global Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diagnostic
  • Therapeutic
  • Other Types
  • 6.2. Global Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Cardiology
  • Gastroenterology
  • Neuroendocrinnology
  • Neurology
  • Nephrology
  • Other Applications
  • 6.3. Global Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Cancer Research Institutes
  • Other End Users

7. Radiopharmaceuticals Market Regional And Country Analysis

  • 7.1. Global Radiopharmaceuticals Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Radiopharmaceuticals Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Radiopharmaceuticals Market

  • 8.1. Asia-Pacific Radiopharmaceuticals Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Radiopharmaceuticals Market

  • 9.1. China Radiopharmaceuticals Market Overview
  • 9.2. China Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Radiopharmaceuticals Market

  • 10.1. India Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Radiopharmaceuticals Market

  • 11.1. Japan Radiopharmaceuticals Market Overview
  • 11.2. Japan Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Radiopharmaceuticals Market

  • 12.1. Australia Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Radiopharmaceuticals Market

  • 13.1. Indonesia Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Radiopharmaceuticals Market

  • 14.1. South Korea Radiopharmaceuticals Market Overview
  • 14.2. South Korea Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Radiopharmaceuticals Market

  • 15.1. Western Europe Radiopharmaceuticals Market Overview
  • 15.2. Western Europe Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Radiopharmaceuticals Market

  • 16.1. UK Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Radiopharmaceuticals Market

  • 17.1. Germany Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Radiopharmaceuticals Market

  • 18.1. France Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Radiopharmaceuticals Market

  • 19.1. Italy Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Radiopharmaceuticals Market

  • 20.1. Spain Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Radiopharmaceuticals Market

  • 21.1. Eastern Europe Radiopharmaceuticals Market Overview
  • 21.2. Eastern Europe Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Radiopharmaceuticals Market

  • 22.1. Russia Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Radiopharmaceuticals Market

  • 23.1. North America Radiopharmaceuticals Market Overview
  • 23.2. North America Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Radiopharmaceuticals Market

  • 24.1. USA Radiopharmaceuticals Market Overview
  • 24.2. USA Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Radiopharmaceuticals Market

  • 25.1. Canada Radiopharmaceuticals Market Overview
  • 25.2. Canada Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Radiopharmaceuticals Market

  • 26.1. South America Radiopharmaceuticals Market Overview
  • 26.2. South America Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Radiopharmaceuticals Market

  • 27.1. Brazil Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Radiopharmaceuticals Market

  • 28.1. Middle East Radiopharmaceuticals Market Overview
  • 28.2. Middle East Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Radiopharmaceuticals Market

  • 29.1. Africa Radiopharmaceuticals Market Overview
  • 29.2. Africa Radiopharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Radiopharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Radiopharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Radiopharmaceuticals Market Competitive Landscape And Company Profiles

  • 30.1. Radiopharmaceuticals Market Competitive Landscape
  • 30.2. Radiopharmaceuticals Market Company Profiles
    • 30.2.1. Cardinal Health
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Curium Pharma
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens Healthineers AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. General Electric Company (GE)
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Radiopharmaceuticals Market Other Major And Innovative Companies

  • 31.1. IBA Group
  • 31.2. Bayer AG
  • 31.3. Lantheus Medical Imaging Inc.
  • 31.4. Bracco Imaging S.p.A.
  • 31.5. Eckert & Ziegler
  • 31.6. Nihon Medi-Physics Co. Ltd.
  • 31.7. Fujifilm Corporation
  • 31.8. ANSTO
  • 31.9. Yantai Dongcheng Pharmaceutical Group Co. Ltd.
  • 31.10. Bracco Imaging SpA.
  • 31.11. Canon Inc.
  • 31.12. China Isotope & Radiation Corporation (CIRC)
  • 31.13. Alliance Medical
  • 31.14. Advanced Accelerator Applications
  • 31.15. JSC Isotope

32. Global Radiopharmaceuticals Market Competitive Benchmarking

33. Global Radiopharmaceuticals Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Radiopharmaceuticals Market

35. Radiopharmaceuticals Market Future Outlook and Potential Analysis

  • 35.1 Radiopharmaceuticals Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Radiopharmaceuticals Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Radiopharmaceuticals Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer